ArticleFrontiers in oncology2023

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients.

Jinhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.